Osteoprotegerin, RANKL, RANK genes polymorphisms in diabetic Charcot neuroosteoarthropathy

被引：0
|
作者：
Korzon-Burakowska, A. [1 ]
Bruhn-Olszewska, B. [2 ]
Jakobkieiwcz-Banecka, J. [2 ]
Wegrzyn, G. [2 ]
机构：
[1] Med Univ, Bialystok, Poland
[2] Univ Gdansk, PL-80952 Gdansk, Poland
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1240
引用
收藏
页码：S497 / S497
页数：1
相关论文
共 50 条
  • [21] RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
    M. Baud’huin
    F. Lamoureux
    L. Duplomb
    F. Rédini
    D. Heymann
    Cellular and Molecular Life Sciences, 2007, 64 : 2334 - 2350
  • [22] RANKL-RANK-OPG Pathway in Charcot Diabetic Foot: Pathophysiology and Clinical-Therapeutic Implications
    Greco, Tommaso
    Mascio, Antonio
    Comisi, Chiara
    Polichetti, Chiara
    Caravelli, Silvio
    Mosca, Massimiliano
    Mondanelli, Nicola
    Troiano, Elisa
    Maccauro, Giulio
    Perisano, Carlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [23] Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
    Hein, Alexander
    Bayer, Christian M.
    Schrauder, Michael G.
    Haeberle, Lothar
    Heusinger, Katharina
    Strick, Reiner
    Ruebner, Matthias
    Lux, Michael P.
    Renner, Stefan P.
    Schulz-Wendtland, Ruediger
    Ekici, Arif B.
    Hartmann, Arndt
    Beckmann, MatthiasW.
    Fasching, Peter A.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [24] Bone immunohistochemistry and plasma levels of RANKL, osteoprotegerin and TNFa in acute Charcot foot
    Eleftheriadou, I.
    Tentolouris, A.
    Anastasiou, I.
    Mourouzis, I.
    Jude, E.
    La Fontaine, J.
    Catrina, E.
    Papadimitriou, C.
    Evangelou, K.
    Tentolouris, N.
    DIABETOLOGIA, 2019, 62 : S462 - S463
  • [25] The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer
    Omar, Heba S.
    Shaker, Olfat G.
    Nassar, Yasser H.
    Marzouk, Samar A.
    ElMarzouky, Mohamed S.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 403 (1-2) : 219 - 229
  • [26] The association between RANKL and osteoprotegerin gene polymorphisms with breast cancer
    Omar, H.
    Shaker, O.
    Nassar, Y.
    Marzouk, S.
    ElMarzouky, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S295 - S295
  • [27] The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer
    Heba S. Omar
    Olfat G. Shaker
    Yasser H. Nassar
    Samar A. Marzouk
    Mohamed S. ElMarzouky
    Molecular and Cellular Biochemistry, 2015, 403 : 219 - 229
  • [28] Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL
    Marley, Kevin
    Bracha, Shay
    Seguin, Bernard
    EXPERIMENTAL CELL RESEARCH, 2015, 338 (01) : 32 - 38
  • [29] Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players
    Banfi, G.
    Corsi, M. M.
    Galliera, E.
    JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2012, 52 (02): : 198 - 201
  • [30] Osteoprotegerin (OPG) and Related Proteins (RANK, RANKL and TRAIL) in Thyroid Disease
    Sumit K. Sood
    Sabapathy Balasubramanian
    Sue Higham
    Malee Fernando
    Barney Harrison
    World Journal of Surgery, 2011, 35 : 1984 - 1992
12345